200 related articles for article (PubMed ID: 36402951)
1. The effect of calcineurin inhibitors on anthropometric measurements in kidney transplant recipients.
Sayilar EI; Ersoy A; Ersoy C; Oruc A; Ayar Y; Sigirli D
BMC Nephrol; 2022 Nov; 23(1):375. PubMed ID: 36402951
[TBL] [Abstract][Full Text] [Related]
2. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
3. An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients.
Sommerer C; Suwelack B; Dragun D; Schenker P; Hauser IA; Witzke O; Hugo C; Kamar N; Merville P; Junge M; Thaiss F; Nashan B;
Kidney Int; 2019 Jul; 96(1):231-244. PubMed ID: 31027892
[TBL] [Abstract][Full Text] [Related]
4. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.
Agarwal SK; Bhowmik D; Mahajan S; Bagchi S
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27775825
[TBL] [Abstract][Full Text] [Related]
5. No Difference Between Tacrolimus and Cyclosporine A on Depression Among Kidney Transplantation Recipients.
Chen H; Liu K; Wei D; Wang P; Zhang G; Chen C; Yuan J
Transplant Proc; 2023 Nov; 55(9):2085-2089. PubMed ID: 37743190
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.
Nankivell BJ; PʼNg CH; OʼConnell PJ; Chapman JR
Transplantation; 2016 Aug; 100(8):1723-31. PubMed ID: 27306529
[TBL] [Abstract][Full Text] [Related]
7. Adequacy of Initial Everolimus Dose, With and Without Calcineurin Inhibitors, in Kidney Transplant Recipients.
Felipe C; Ferreira A; Bessa A; Abait T; Perez JD; Casarini DE; Medina-Pestana J; Tedesco H
Ther Drug Monit; 2018 Feb; 40(1):52-58. PubMed ID: 29271815
[TBL] [Abstract][Full Text] [Related]
8. Incidence of development of obesity after heart transplantation according to the calcineurin inhibitor.
López-Vilella R; Sánchez-Lázaro IJ; Martínez-Dolz L; Almenar-Bonet L; Marqués-Sulé E; Melero-Ferrer J; Portolés-Sanz M; Rivera-Otero M; Domingo-Valero D; Montero-Argudo A
Transplant Proc; 2015; 47(1):127-9. PubMed ID: 25645789
[TBL] [Abstract][Full Text] [Related]
9. Time-Dependent and Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Converted from Tacrolimus to Sirolimus Regimens.
Felix MJ; Felipe CR; Tedesco-Silva H; Osmar Medina-Pestana J
Pharmacotherapy; 2016 Feb; 36(2):152-65. PubMed ID: 26799522
[TBL] [Abstract][Full Text] [Related]
10. Insulin Resistance in Nonobese Renal Allograft Recipients on Maintenance Doses of Cyclosporine or Tacrolimus.
Soypacaci Z; Akgun AO; Sengul S; Keven K
Transplant Proc; 2019 Sep; 51(7):2339-2342. PubMed ID: 31402251
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.
Beckebaum S; Armstrong VW; Cicinnati VR; Streit F; Klein CG; Gerken G; Paul A; Oellerich M
Ther Drug Monit; 2009 Apr; 31(2):205-10. PubMed ID: 19307937
[TBL] [Abstract][Full Text] [Related]
12. Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy.
Tsai MK; Wu FL; Lai IR; Lee CY; Hu RH; Lee PH
Int J Artif Organs; 2009 Jun; 32(6):371-80. PubMed ID: 19670189
[TBL] [Abstract][Full Text] [Related]
13. Effect of a new functional CYP3A4 polymorphism on calcineurin inhibitors' dose requirements and trough blood levels in stable renal transplant patients.
Elens L; van Schaik RH; Panin N; de Meyer M; Wallemacq P; Lison D; Mourad M; Haufroid V
Pharmacogenomics; 2011 Oct; 12(10):1383-96. PubMed ID: 21902502
[TBL] [Abstract][Full Text] [Related]
14. Calcineurin inhibitors and post-transplant weight gain.
Ersoy A; Baran B; Ersoy C; Kahvecioglu S; Akdag I
Nephrology (Carlton); 2008 Oct; 13(5):433-9. PubMed ID: 18331443
[TBL] [Abstract][Full Text] [Related]
15. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
Tönshoff B; Höcker B
Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
[TBL] [Abstract][Full Text] [Related]
16. Influence of Calcineurin Inhibitor Choice on Outcomes in Kidney Transplant Recipients Aged ≥60 Y: A Collaborative Transplant Study Report.
Echterdiek F; Döhler B; Latus J; Schwenger V; Süsal C
Transplantation; 2022 Apr; 106(4):e212-e218. PubMed ID: 35066544
[TBL] [Abstract][Full Text] [Related]
17. Impact of tacrolimus versus cyclosporin A on renal function during the first year after heart transplant.
Shiraishi Y; Amiya E; Hatano M; Katsuki T; Bujo C; Tsuji M; Nitta D; Maki H; Ishida J; Kagami Y; Endo M; Kimura M; Ando M; Shimada S; Kinoshita O; Ono M; Komuro I
ESC Heart Fail; 2020 Aug; 7(4):1842-1849. PubMed ID: 32445260
[TBL] [Abstract][Full Text] [Related]
18. Potential cardiovascular risk factors in paediatric renal transplant recipients.
Ferraris JR; Ghezzi L; Waisman G; Krmar RT
Pediatr Nephrol; 2006 Jan; 21(1):119-25. PubMed ID: 16252106
[TBL] [Abstract][Full Text] [Related]
19. Systematic Review of Calcineurin Inhibitors and Incidence of Skin Malignancies after Kidney Transplantation in Adult Patients: A Study of 309,551 Cases.
Kulbat A; Richter K; Stefura T; Kołodziej-Rzepa M; Kisielewski M; Wojewoda T; Wysocki WM
Curr Oncol; 2023 Jun; 30(6):5727-5737. PubMed ID: 37366913
[TBL] [Abstract][Full Text] [Related]
20. Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients.
Gathogo E; Harber M; Bhagani S; Levy J; Jones R; Hilton R; Davies G; Post FA;
Transplantation; 2016 Apr; 100(4):871-8. PubMed ID: 26413990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
